Pectinesterases From Mature, Unripe Peach Fruit Bind Strongly to Pectic Polysaccharides

1995 ◽  
Vol 22 (6) ◽  
pp. 977 ◽  
Author(s):  
H Glover ◽  
CJ Brady

Contrary to previous findings, the level of the pectin de-esterifying enzyme, pectinesterase (PE; EC 3.1 .1. 11), is shown to be much higher in mature, green peach fruit than in ripe fruit. Aqueous buffers readily extracted three pectinesterase isoforms from ripe fruit but only a portion of the activity from mature, green fruit. In mature, green fruit extracts the enzyme precipitated when the ionic strength was lowered; consequently isoforms could not be recovered by ion exchange chromatography. In extraction residues from mature, green fruit, residual PE could be measured as active enzyme and, when denatured, could be detected by immunological techniques. Extraction of the enzyme was enhanced after digestion of the tissue with pectin lyase. The extracted enzyme fractionated as a large molecular weight complex rich in uronic acid, rhamnose, galactose and arabinose. After further digestion with endo-β-1,4- galactanase, the enzyme was in two fractions of smaller size but with residual carbohydrate. When mature, green and ripe fruit tissue were co-extracted, the recovered activity was as predicted from independently extracted tissues demonstrating that enzyme activity was not influenced by inhibitors contributed by either tissue type. Isoforms known to be present in the ripe fruit were recovered from extracts of the mixed tissues. It is concluded that PE in extracts of mature, green fruit has a strong association with pectic polymers and this has lead to its underestimation in previous studies. It is suggested that such an association with pectin polymers in vivo may regulate enzyme activity and enzyme turnover.

1991 ◽  
Vol 18 (1) ◽  
pp. 65 ◽  
Author(s):  
BJ Pogson ◽  
CJ Brady ◽  
GR Orr

Endopolygalacturonase [poly(1,4-α-galacturonide) glycanohydrolase EC 3.2.1.151 occurs in tomato fruit in three molecular forms- PG1, PG2A, PG2B. Trace amounts of PG1, 1-10 pkat g-1 are shown to occur in mature-green fruit as compared to 17 nkat in ripe fruit. As polygalacturonase activity increases through ripening, the percentage of the activity due to PG1 decreases progressively from 100 to less than 20. On fully or partly demethylated substrates, PG1 is more active than PG2 when the ionic strength is that expected in the tissue apoplast. A method for purifying PGI from ripe fruit is described. PG1 preparations contain polypeptides of Mr 45, 43 and 38 thousand. The Mr 43 thousand and 45 thousand components correspond in size to PG2A and PG2B and are detected by antisera raised against PG2A. The M, 38 thousand polypeptide is immunologically distinct. From carbohydrate and amino acid analyses, this polypeptide appears to contain 2870 carbohydrate as glucosamine, mannose, xylose and fucose attached to a polypeptide of estimated Mr 28 342 that is rich in tyrosine and glycine. A method for purifying the subunits of PG1 by cation exchange chromatography in 6 M urea is described. PG2A and PG2B were separated by column chromatography and shown to have identical N-terminal sequences, and serine at the C-terminus. PG2A and PG2B are confirmed as two glycoforms of the one polypeptide. The possibility that PGl consists of populations of molecules containing either PG2A or PG2B coupled with the Mr 38 thousand polypeptide is discussed.


1996 ◽  
Vol 314 (2) ◽  
pp. 491-495 ◽  
Author(s):  
Peter VAN DIJKEN ◽  
Jan C. T. BERGSMA ◽  
Hoebert S. HIEMSTRA ◽  
Berber DE VRIES ◽  
Jeroen VAN DER KAAY ◽  
...  

The small ion lithium, a very effective agent in the treatment of manic depressive patients, inhibits the mammalian enzyme inositol monophosphatase, which is proposed as the biological target for the effects of lithium. In this study we investigated Dictyostelium discoideum inositol monophosphatase activity. Partial purification of the proteins in the soluble cell fraction using anion-exchange chromatography revealed the presence of at least three enzyme activities capable of degrading inositol monophosphate isomers. The first activity was similar to the monophosphatase found in mammalian cells, as it degraded Ins(4)P, Ins(1)P and to a lesser extent Ins(3)P, was dependent on MgCl2 and inhibited by LiCl in a non-competitive manner. The second enzyme activity was specific for Ins(4)P; the enzyme activity was not dependent on MgCl2 and not inhibited by LiCl. The third monophosphatase activity degraded especially Ins(3)P, but also Ins(4)P and Ins(1)P; increasing concentrations of MgCl2 inhibited this enzyme activity, whereas LiCl had no effect. In vivo, LiCl induces a reduction of inositol levels by about 20%. In [3H]inositol-labelled cells LiCl causes a 6-fold increase in the radioactivity of [3H]Ins(1)P, a doubling of [3H]Ins(4)P and a slight decrease in the radioactivity in [3H]Ins(3)P. These data indicate that the biological effects of lithium in Dictyostelium are not due to depletion of the inositol pool by inhibition of inositol monophosphatase activity.


HortScience ◽  
1991 ◽  
Vol 26 (1) ◽  
pp. 66-68 ◽  
Author(s):  
John L. Maas ◽  
Shiow Y. Wang ◽  
Gene J. Galletta

Ellagic acid in tissue extracts of green and red-ripe strawberries (Fragaria × ananassa Duch.) was detected and quantified by HPLC. Ellagic acid content of green fruit pulp ranged from 1.32 to 8.43 mg·g-1 of tissue dry weight (mean 3.36 mg·g-l) and in achenes of green fruit from 1.32 to 20.73 mg·g-1 (mean 7.24). Ellagic acid content of red fruit pulp at one location for 35 cultivars and selections ranged from 0.43 to 4.64 mg·g-1 of dry weight (mean 1.55) and from 0.43 to 3.47 mg·g-l (mean 1.45) for 15 clones at another location. Achenes from red-ripe fruit ranged from 1.37 to 21.65 mg·g-1 (mean 8.46) for 34 clones at one location and from 2.81 to 18.37 mg·g-1 (mean 8.93) for 15 clones at another location. Leaf ellagic acid content ranged from 8.08 to 32.30 mg·g-1 of dry weight (mean 14.71) for 13 clones examined. Large differences in ellagic acid content were found among cultivars, but tissue values were not consistent within cultivars. Values from one tissue type did not correlate consistently with values of the other tissues. Sufficient variation was found among cultivars to suggest that increased ellagic acid levels may be achieved in progeny from crosses with selected parental material.


1987 ◽  
Vol 58 (03) ◽  
pp. 921-926 ◽  
Author(s):  
E Seifried ◽  
P Tanswell

SummaryIn vitro, concentration-dependent effects of rt-PA on a range of coagulation and fibrinolytic assays in thawed plasma samples were investigated. In absence of a fibrinolytic inhibitor, 2 μg rt-PA/ml blood (3.4 μg/ml plasma) caused prolongation of clotting time assays and decreases of plasminogen (to 44% of the control value), fibrinogen (to 27%), α2-antiplasmin (to 5%), FV (to 67%), FVIII (to 41%) and FXIII (to 16%).Of three inhibitors tested, a specific polyclonal anti-rt-PA antibody prevented interferences in all fibrinolytic and most clotting assays. D-Phe-Pro-Arg-CH2Cl (PPACK) enabled correct assays of fibrinogen and fibrinolytic parameters but interfered with coagulometric assays dependent on endogenous thrombin generation. Aprotinin was suitable only for a restricted range of both assay types.Most in vitro effects were observed only with rt-PA plasma concentrations in excess of therapeutic values. Nevertheless it is concluded that for clinical application, collection of blood samples on either specific antibody or PPACK is essential for a correct assessment of in vivo effects of rt-PA on the haemostatic system in patients undergoing fibrinolytic therapy.


1981 ◽  
Vol 46 (03) ◽  
pp. 658-661 ◽  
Author(s):  
C Korninger ◽  
J M Stassen ◽  
D Collen

SummaryThe turnover of highly purified human extrinsic plasminogen activator (EPA) (one- and two-chain form) was studied in rabbits. Following intravenous injection, EPA-activity declined rapidly. The disappearance rate of EPA from the plasma could adequately be described by a single exponential term with a t ½ of approximately 2 min for both the one-chain and two-chain forms of EPA.The clearance and organ distribution of EPA was studied by using 125I-labeled preparations. Following intravenous injection of 125I-1abeled EPA the radioactivity disappeared rapidly from the plasma also with a t ½ of approximately 2 min down to a level of 15 to 20 percent, followed by a small rise of blood radioactivity. Gel filtration of serial samples revealed that the secondary increase of the radioactivity was due to the reappearance of radioactive breakdown products in the blood. Measurement of the organ distribution of 125I at different time intervals revealed that EPA was rapidly accumulated in the liver, followed by a release of degradation products in the blood.Experimental hepatectomy markedly prolonged the half-life of EPA in the blood. Blocking the active site histidine of EPA had no effect on the half-life of EPA in blood nor on the gel filtration patterns of 125I in serial plasma samples.It is concluded that human EPA is rapidly removed from the blood of rabbits by clearance and degradation in the liver. Recognition by the liver does not require a functional active site in the enzyme. Neutralization in plasma by protease inhibitors does not represent a significant pathway of EPA inactivation in vivo.


1997 ◽  
Vol 78 (03) ◽  
pp. 1150-1156 ◽  
Author(s):  
Christina Jern ◽  
Heléne Seeman-Lodding ◽  
Bjӧrn Biber ◽  
Ola Winsӧ ◽  
Sverker Jern

SummaryExperimental data indicate large between-organs variations in rates of synthesis of tissue-type plasminogen activator (t-PA), which may reflect important differences in the capacity for constitutive and stimulated t-PA release from the vascular endothelium. In this report we describe a new multiple-organ experimental in vivo model for simultaneous determinations of net release/uptake rates of t-PA across the coronary, splanchnic, pulmonary, and hepatic vascular beds. In eleven intact anesthetized pigs, blood samples were obtained simultaneously from the proximal aorta, coronary sinus, pulmonary artery, and portal and hepatic veins. Plasma flows were monitored separately for each vascular region. Total plasma t-PA was determined by ELISA with a porcine t-PA standard. Regional net release/uptake rates were defined as the product of arteriovenous concentration gradients and local plasma flows. The net release of t-PA across the splanchnic vascular bed was very high, with a mean output of 1,919 ng total t-PA X min-1 (corresponding to 90 ng per min and 100 g tissue). The net coronary t-PA release was 68 ng X min-1 (30 ng X min-1 X 100 g"1)- Pulmonary net fluxes of t-PA were variable without any significant net t-PA release. The net hepatic uptake rate was 4,855 ng X min-1 (436 ng X min-1 X 100 g-1). Net trans-organ changes of active t-PA mirrored those of total t-PA. The results demonstrate marked regional differences in net release rates of t-PA in vivo. The experimental model we present offers new possibilities for evaluation of regional secretion patterns in the intact animal.


1983 ◽  
Vol 50 (02) ◽  
pp. 518-523 ◽  
Author(s):  
C Kluft ◽  
A F H Jie ◽  
R A Allen

SummaryFunctional assay of extrinsic (tissue-type) plasminogen activator (EPA) in plasma on fibrin plates was evaluated. Using specific quenching antibodies, we demonstrated the method to be specific for EPA under all conditions tested. Contributions of urokinases and intrinsic activators were excluded. The quantity of EPA in blood samples, as compared with purified uterine tissue activator, shows 1 blood activator unit (BAU) to be comparable to 0.93 ng.The median values for EPA activity for healthy volunteers were: baseline, 1.9 BAU/ml (n = 123); diurnal, 5.5 BAU/ml (n = 12); DDAVP administration, 11.7 BAU/ml (n = 39); exhaustive exercise, 25 BAU/ml (n = 24); venous occlusion (15 min), 35 BAU/ml (n = 61). A large inter-individual variation in EPA activity was found, while individual baseline values tended to be constant for periods of weeks.In vitro in blood EPA activity shows a disappearance of 50% in about 90 min at 37° C; EPA activity in euglobulin fractions is stable for ≤2 hr at 37° C.A rapid decrease in EPA activity occurs in vivo, as noted after extracorporal circulation and exercise stimulation (t½ decay, 2-5 min).


2019 ◽  
Vol 26 (7) ◽  
pp. 494-501 ◽  
Author(s):  
Sameer Suresh Bhagyawant ◽  
Dakshita Tanaji Narvekar ◽  
Neha Gupta ◽  
Amita Bhadkaria ◽  
Ajay Kumar Gautam ◽  
...  

Background: Diabetes and hypertension are the major health concern and alleged to be of epidemic proportions. This has made it a numero uno subject at various levels of investigation. Glucosidase inhibitor provides the reasonable option in treatment of Diabetes Mellitus (DM) as it specifically targets post prandial hyperglycemia. The Angiotensin Converting Enzyme (ACE) plays an important role in hypertension. Therefore, inhibition of ACE in treatment of elevated blood pressure attracts special interest of the scientific community. Chickpea is a food legume and seeds contain carbohydrate binding protein- a lectin. Some of the biological properties of this lectin hitherto been elucidated. Methods: Purified by ion exchange chromatography, chickpea lectin was tested for its in vitro antioxidant, ACE-I inhibitory and anti-diabetic characteristic. Results: Lectin shows a characteristic improvement over the synthetic drugs like acarbose (oral anti-diabetic drug) and captopril (standard antihypertensive drug) when, their IC50 values are compared. Lectin significantly inhibited α-glucosidase and α-amylase in a concentration dependent manner with IC50 values of 85.41 ± 1.21 ҝg/ml and 65.05 ± 1.2 µg/ml compared to acarbose having IC50 70.20 ± 0.47 value of µg/ml and 50.52 ± 1.01 µg/ml respectively. β-Carotene bleaching assay showed antioxidant activity of lectin (72.3%) to be as active as Butylated Hydroxylanisole (BHA). In addition, lectin demonstrated inhibition against ACE-I with IC50 value of 57.43 ± 1.20 µg/ml compared to captopril. Conclusion: Lectin demonstrated its antioxidant character, ACE-I inhibition and significantly inhibitory for α-glucosidase and α-amylase seems to qualify as an anti-hyperglycemic therapeutic molecule. The biological effects of chickpea lectin display potential for reducing the parameters of medically debilitating conditions. These characteristics however needs to be established under in vivo systems too viz. animals through to humans.


Sign in / Sign up

Export Citation Format

Share Document